Survival of Children With Critical Congenital Heart Defects in the National Birth Defects Prevention Study

Nina E Forestieri1, Andrew F Olshan2, Matthew E Oster3

  • 1Birth Defects Monitoring Program, State Center for Health Statistics, Division of Public Health, North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA.

Birth Defects Research
|September 11, 2024
PubMed

Insights

Survival for infants with critical congenital heart defects (CCHDs) is over 85% at one year. However, univentricular defects significantly reduce survival, and social factors impact biventricular defect outcomes.

Area of Science:

  • Pediatric Cardiology
  • Public Health
  • Epidemiology

Background:

  • Critical congenital heart defects (CCHDs) contribute significantly to infant morbidity and mortality.
  • Understanding survival rates and influencing factors is crucial for improving outcomes in affected children.

Purpose of the Study:

  • To estimate the survival probabilities of infants diagnosed with nonsyndromic CCHDs.
  • To investigate the relationship between various exposures and survival, stratified by CCHD severity (univentricular vs. biventricular).

Main Methods:

  • Analysis of 4380 infants with CCHDs from the National Birth Defects Prevention Study (1999-2011).
  • Kaplan-Meier survival functions and Cox proportional hazards modeling were employed.
  • Survival was assessed overall and stratified by defect severity, with adjustments for demographic and clinical factors.

Main Results:

  • One-year survival was 85.8% and five-year survival was 83.7%.
  • Univentricular CCHDs had substantially lower five-year survival (65.3%) compared to biventricular CCHDs (89.0%).
  • Clinical factors like preterm birth impacted survival in both groups, while sociodemographic factors primarily affected biventricular cases.

Conclusions:

  • Most mortality in CCHDs occurs within the first year of life.
  • Univentricular defects are associated with poorer survival outcomes.
  • Social determinants of health play a critical role in survival among children with biventricular CCHDs.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...